Tuberculosis (TB) represents a global public health threat and is the leading cause of morbidity 25 and mortality worldwide. Effective control of TB is complicated with the emergence of multidrug 26
INTRODUCTION
Tuberculosis (TB) represents a disease of global public health importance and a leading cause of 48 morbidity and mortality worldwide, surpassing HIV/AIDS (1, 2) . One third of the world's 49 population is currently infected with Mycobacterium tuberculosis, with more than 10 million new 50 cases of active TB reported worldwide resulting in more than 1.6 million deaths annually. The 51 emergence of drug-resistant TB and the increasing incidence of multidrug-resistant (MDR) and, 52 more recently, of extensively drug-resistant (XDR) and totally drug-resistant (TDR) M. 53 tuberculosis strains are a highly significant public health threat and jeopardize current efforts to 54 TB control and prevention (3-5). 55
Besides the ability to acquire mutations in target genes conferring resistance to 56 antimicrobial drugs, M. tuberculosis strains also show a high degree of intrinsic resistance to most 57 common antibiotics (6). This allows the mycobacteria to efficiently resist anti-tuberculous 58 treatment. As a consequence, the molecular characterization of drug-resistant M. tuberculosis 59 strains remains technically challenging (7-9). There is an urgent need to develop alternative and 60 more sensitive approaches to identify M. tuberculosis strains in order to implement better measures 61 to minimize the acquisition of further drug resistance, prevent TB transmission, and ultimately 62 improve TB control and prevention strategies. 63
The M. tuberculosis cell wall has a complex composition and structure. It is considered to 64 be a major virulence factor and to promote the natural resistance of M. tuberculosis to antibiotics 65 (10). Mycolic acids represent the hallmark component of the M. tuberculosis cell wall and their 66 biosynthesis and regulation are the targets of isoniazid (INH), one of the cornerstone drug of TB 67 treatment (11, 12) . Interestingly, the cell wall is significantly thicker in drug-resistant M.
tuberculosis strains compared to drug-sensitive strains, further underscoring the importance of 69 mycolic acids biosynthesis in INH-resistant M. tuberculosis strains (13). 70
Cell wall lipids in M. tuberculosis play a significant role in modulating the host immune 71 response, as well as its pathogenic processes and virulence (14-17). However, our understanding 72 of the host-M. tuberculosis interaction is still limited, and many fundamental gaps remain in how 73 this interaction could be altered in response to different M. tuberculosis strains. Infections with 74 different M. tuberculosis genotypes have major impacts on host-pathogen interaction, which can 75 lead to substantial differences in the host immune responses (18-20). Some mycobacterial lineages 76 (e.g., Beijing) even showed polymorphic properties in immune response genes, suggesting a 77 possible human-pathogen co-evolution (21). The immune response of infected macrophages also 78 showed a wide variation in the response to different M. tuberculosis lineages (22). However, 79 further work is needed to explore the host immune response to different M. tuberculosis strains. In 80 this study, we tackled this question and investigated the host immune response to different M. 81 tuberculosis strains, including avirulent or virulent and rifampin-resistant or isoniazid-resistant 82 strains in THP-1 cells. Shifting the focus on the host-pathogen interaction in M. tuberculosis 83 infection and the identification of specific host responses to M. tuberculosis strains have the 84 potential to develop biomarkers for novel and more sensitive diagnostic tools for TB. The 85 identification of TB patients at an early stage, particularly those carrying drug-resistant strains, is 86 crucial in order to begin an appropriate therapy as quickly as possible and improve our efforts for 87 TB control. are resistant to isoniazid and rifampin, respectively. We used two time points for infection (4 and 102 24 hours) in order to monitor differences in gene expression patterns for differentially expressed 103 genes. In addition to the infected THP-1 samples, we also used uninfected control cells (mock-104 infected with PBS) as negative controls. 105
106

RNA isolation and processing 107
Total RNA was extracted from controls and infected cells (10 samples in total, with 5 samples for 108 each time point), using Trizol according to the manufacturer's protocol. RNA was then suspended 109 in RNase-free water and stored at -80°C until further use. RNA quality was assessed to verify its 110 integrity using Agilent 2100 Bioanalyzer (Agilent Technologies) and RNA quantity was evaluated 111 by spectrophotometry using NanoDrop 2000 (NanoDrop Technologies). All RNA samples showed 112 good RNA yield and no RNA degradation. Total RNA was then reverse transcribed to cDNA, 113 amplified, labeled and hybridized to separate arrays using the GeneChip Human Exon 1.0 ST profiling, we used triplicate hybridization assays in our microarray experiments in order to assess 116 variability among independent labeling reactions and hybridizations. Quality control of the 117 hybridized arrays was also performed for each sample. A visual inspection of the scanned images 118 was conducted looking for any defects, areas of high background, or areas of low signal. The spike-119 in controls were checked as well to examine for hybridization uniformity. 120 121
Microarray data analysis 122
Data from all 10 samples were preprocessed, summarized at the transcript-cluster (gene) level, and 123 RMA normalized using Affymetrix Power Tools. Prior to differential expression analysis, low-124 variability genes were filtered out, leaving 13,460 genes. Differential expression analyses were 125 conducted using the R/Bioconductor package limma (23). Significant differential expression was 126 defined by an adjusted p-value of less than 0.05. The visualization of the identified differentially 127 expressed genes in the volcano plots was performed using base R graphics. 128
129
RESULTS
130
In this study, we generated gene expression profiles of THP-1 cell lines infected with different 131 Our study showed major differences in the host response to different M. tuberculosis strains. We 168 also showed that the infection with H37Rv-INH-R induced an unexpected overexpression of ISGs 169 in THP-1 cells. Our data indicated that STAT1 is the major transcription factor associated with the strains harbor defined genetic mutations associated with resistance to this drug, which complicates 198 efforts to identify those strains. There are also INH resistance-conferring mutations that cannot be 199 detected by current molecular diagnostics approaches (33). In addition, some studies indicated that 200 some M. tuberculosis strains acquire drug resistance at higher rates, suggesting a higher mutation 201 rate in these strains and a higher probability that these strains will develop multidrug resistance 202 (47, 48).
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